SIGA Technologies, Inc. (SIGA)

Market Cap	422.00M
Revenue (ttm)	173.73M
Net Income (ttm)	85.71M
Shares Out	71.40M
EPS (ttm)	1.20
PE Ratio	4.94
Forward PE	5.68
Dividend	$0.60 (10.15%)
Ex-Dividend Date	n/a

Volume	487,743
Open	5.88
Previous Close	6.03
Day's Range	5.71 - 6.05
52-Week Range	4.26 - 12.83
Beta	0.90
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 7, 2024

About SIGA

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Sep 9, 1997
• Employees: 45
• Stock Exchange: NASDAQ
• Ticker Symbol: SIGA
• Website: https://www.siga.com

Financial Performance

In 2023, SIGA Technologies's revenue was $139.92 million, an increase of 26.31% compared to the previous year's $110.78 million. Earnings were $68.07 million, an increase of 100.76%.